NCT02063789 - An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Immune Thrombocytopenia

Interventions

DRUG

Human immunoglobulin intravenous

After GC5107A Intravenous injection, evaluate platelet increase

Trial Locations (14)

Chungnam National University Hospital, Daejeon

Daegu Catholic University Medical Center, Deagu

Chonnam National University Hwasun Hospital, Hwasun

Gachon University Gil Medical Center, Incheon

Chonbuk National University Hospital, Jeonju

Pusan National University Hospital, Pusan

Seoul National University Bundang Hospital, Seongnam

Asan Medical Center, Seoul

CHA Budang Medical Center, Seoul

Ewha Womans University Medical Center, Seoul

Samsung Medical Center, Seoul

Severance Hospital, Seoul

Soon Chung Hyang University Hospital, Seoul

VHS Medical Center, Seoul